{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:04:53Z","timestamp":1759482293413,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Invicro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Expression of the translocator protein (TSPO) on inflammatory cells has facilitated imaging of synovitis with TSPO-targeted positron emission tomography (PET). We aimed to quantitatively assess the specificity of the second-generation TSPO PET radioligand, [<jats:sup>11<\/jats:sup>C]PBR28, and to generate simplified PET protocols in patients with inflammatory joint disease (IJD) in this pilot study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Three IJD patients (two rheumatoid arthritis and one osteoarthritis) with knee involvement underwent dynamic [<jats:sup>11<\/jats:sup>C]PBR28-PET scans before and after administration of 90\u00a0mg of oral emapunil (XBD-173), a TSPO ligand the same day. Radial arterial blood sampling was performed throughout the scan, and total radioactivity and radioactive metabolites were obtained. A semi-automated method was used to generate regions of interest. Standardized uptake value (SUV) and SUV ratio corrected for activity in bone and blood between 50 and 70\u00a0min (SUVr<jats:sub>50\u201370<\/jats:sub> bone, SUVr<jats:sub>50\u201370<\/jats:sub> blood, respectively) and PET volume of distribution (<jats:italic>V<\/jats:italic><jats:sub>T<\/jats:sub>) of the radioligand were calculated.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A mean [<jats:sup>11<\/jats:sup>C]PBR28 radioactivity of 378 (range 362\u2013389) MBq was administered. A significant decrease (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in <jats:italic>V<\/jats:italic><jats:sub>T<\/jats:sub>, SUVr<jats:sub>50\u201370<\/jats:sub> bone and SUVr<jats:sub>50\u201370<\/jats:sub> blood observed after oral emapunil confirmed the TSPO specificity of [<jats:sup>11<\/jats:sup>C]PBR28. A decrease in SUV was not observed in the post-block scan.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>[<jats:sup>11<\/jats:sup>C]PBR28 is TSPO-specific radioligand in IJD patients. Simplified PET protocols with static PET acquisition can be used in the management and evaluation of novel therapeutics that target TSPO overexpressing cells.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-020-00736-9","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T10:05:56Z","timestamp":1607335556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Specificity of translocator protein-targeted positron emission tomography in inflammatory joint disease"],"prefix":"10.1186","volume":"10","author":[{"given":"Yusuf","family":"Helo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham E.","family":"Searle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Borghese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5747-7577","authenticated-orcid":false,"given":"Azeem","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"736_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcdb.2016.05.009","volume":"62","author":"P Bhattaram","year":"2017","unstructured":"Bhattaram P, Chandrasekharan U. The joint synovium: a critical determinant of articular cartilage fate in inflammatory joint diseases. Semin Cell Dev Biol. 2017;62:86\u201393.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"736_CR2","first-page":"554","volume":"26","author":"J Furuzawa-Carballeda","year":"2008","unstructured":"Furuzawa-Carballeda J, Macip-Rodriguez PM, Cabral AR. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin Exp Rheumatol. 2008;26(4):554\u201360.","journal-title":"Clin Exp Rheumatol"},{"key":"736_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/03009748809102962","volume":"76","author":"SA Allard","year":"1988","unstructured":"Allard SA, Maini RN, Muirden KD. Cells and matrix expressing cartilage components in fibroblastic tissue in rheumatoid pannus. Scand J Rheumatol Suppl. 1988;76:125\u20139.","journal-title":"Scand J Rheumatol Suppl"},{"issue":"5 Suppl 35","key":"736_CR4","first-page":"S18","volume":"22","author":"AK Brown","year":"2004","unstructured":"Brown AK, Wakefield RJ, Conaghan PG, Karim Z, O\u2019Connor PJ, Emery P. New approaches to imaging early inflammatory arthritis. Clin Exp Rheumatol. 2004;22(5 Suppl 35):S18-25.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"736_CR5","doi-asserted-by":"publisher","first-page":"R70","DOI":"10.1186\/ar4509","volume":"16","author":"YY Gent","year":"2014","unstructured":"Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Kassiou M, et al. Promising potential of new generation translocator protein tracers providing enhanced contrast of arthritis imaging by positron emission tomography in a rat model of arthritis. Arthritis Res Ther. 2014;16(2):R70.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"736_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2967\/jnumed.117.202200","volume":"59","author":"N Narayan","year":"2018","unstructured":"Narayan N, Owen DR, Mandhair H, Smyth E, Carlucci F, Saleem A, et al. Translocator protein as an imaging marker of macrophage and stromal activation in rheumatoid arthritis pannus. J Nucl Med. 2018;59(7):1125\u201332.","journal-title":"J Nucl Med"},{"key":"736_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-015-0770-7","volume":"17","author":"YY Gent","year":"2015","unstructured":"Gent YY, Ter Wee MM, Voskuyl AE, den Uyl D, Ahmadi N, Dowling C, et al. Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study. Arthritis Res Ther. 2015;17:266.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"736_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen DR, Yeo AJ, Gunn RN, Song K, Wadsworth G, Lewis A, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab. 2012;32(1):1\u20135.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"736_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/jcbfm.2014.46","volume":"34","author":"DR Owen","year":"2014","unstructured":"Owen DR, Guo Q, Kalk NJ, Colasanti A, Kalogiannopoulou D, Dimber R, et al. Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study. J Cereb Blood Flow Metab. 2014;34(6):989\u201394.","journal-title":"J Cereb Blood Flow Metab"},{"key":"736_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13550-015-0103-5","volume":"5","author":"A Saleem","year":"2015","unstructured":"Saleem A, Searle GE, Kenny LM, Huiban M, Kozlowski K, Waldman AD, et al. Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer. EJNMMI Res. 2015;5:30.","journal-title":"EJNMMI Res"},{"issue":"6","key":"736_CR11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","volume":"21","author":"RN Gunn","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab. 2001;21(6):635\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"736_CR12","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"736_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13550-020-0605-7","volume":"10","author":"EA Woodcock","year":"2020","unstructured":"Woodcock EA, Schain M, Cosgrove KP, Hillmer AT. Quantification of [(11)C]PBR28 data after systemic lipopolysaccharide challenge. EJNMMI Res. 2020;10(1):19.","journal-title":"EJNMMI Res"},{"issue":"5","key":"736_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2967\/jnumed.114.146027","volume":"56","author":"CH Lyoo","year":"2015","unstructured":"Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, et al. Cerebellum can serve as a pseudo-reference region in alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med. 2015;56(5):701\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"736_CR15","doi-asserted-by":"publisher","first-page":"e30623","DOI":"10.1371\/journal.pone.0030623","volume":"7","author":"WW Kam","year":"2012","unstructured":"Kam WW, Meikle SR, Zhou H, Zheng Y, Blair JM, Seibel M, et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. PLoS ONE. 2012;7(1):e30623.","journal-title":"PLoS ONE"},{"issue":"5","key":"736_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0042-107795","volume":"49","author":"N Sarubin","year":"2016","unstructured":"Sarubin N, Baghai TC, Lima-Ojeda JM, Melchner D, Hallof-Buestrich H, Wolf L, et al. Translocator protein (TSPO) expression in platelets of depressed patients decreases during antidepressant therapy. Pharmacopsychiatry. 2016;49(5):204\u20139.","journal-title":"Pharmacopsychiatry"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-020-00736-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-020-00736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T10:37:56Z","timestamp":1607337476000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-020-00736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1186\/s13550-020-00736-9","relation":{},"ISSN":["2191-219X"],"issn-type":[{"type":"electronic","value":"2191-219X"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"3 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All participants provided written informed consent to take part in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors provide permit publication of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GES is an employee, and AS and YH are ex-employees of Invicro, which funded and sponsored the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}